AIM OF THE STUDY: The aim of the study was to investigate perioperative prognostic factors and long-term outcome following conventional open repair (COR) of thoracoabdominal aortic aneurysms (TAAA) and chronic expanding aortic dissections (CEAD). PATIENTS AND METHODS: Between March 1993 and December 2005, 92 patients underwent elective COR for TAAA or CEAD in our institution. Passive distal aortic perfusion during cross-clamping was used in 36 patients (39%). Medical records and imaging studies of all patients were reviewed. Follow-up included history, physical examination and CT or MR angiography. Median follow-up was 40 months (range 1-139 months). RESULTS: Intraoperative, 30-day and in-hospital mortality rates were 2%, 8% and 12%, respectively. The estimated survival rate after 5 years was 70% and 43% of all deaths were cardiac related. The paraplegia rate was 10%, the rate of patients developing chronic renal failure requiring hemodialysis was 3% and 21% of patients required surgical revision. In multivariate analyses the need for surgical revision (OR: 8.465; CI: 0.802-89.318; p=0.024) and postoperative elevated serum transaminase values (OR: 1.009; CI: 1.002-1.017; p=0.017) independently predicted 30-day mortality. Peripheral arterial disease (OR: 4.41; CI:1.672-11.611; p=0.003), intraoperative complications such as disseminated intravasal coagulation and asystole (OR: 4.28; CI: 1.128-16.267; p=0.033), postoperative elevated bilirubin values >2.5 mg/dl (OR: 1.06; CI: 1.009-1.112; p=0.019), and postoperative ventilation >7 days (OR: 7.79; CI: 2.499-24.246; p<0,0001) independently predicted long-term mortality. CONCLUSION: Postoperative elevated liver values represent negative prognostic factors and may indicate a more standardized use of active shunt systems for organ perfusion.
AIM OF THE STUDY: The aim of the study was to investigate perioperative prognostic factors and long-term outcome following conventional open repair (COR) of thoracoabdominal aortic aneurysms (TAAA) and chronic expanding aortic dissections (CEAD). PATIENTS AND METHODS: Between March 1993 and December 2005, 92 patients underwent elective COR for TAAA or CEAD in our institution. Passive distal aortic perfusion during cross-clamping was used in 36 patients (39%). Medical records and imaging studies of all patients were reviewed. Follow-up included history, physical examination and CT or MR angiography. Median follow-up was 40 months (range 1-139 months). RESULTS: Intraoperative, 30-day and in-hospital mortality rates were 2%, 8% and 12%, respectively. The estimated survival rate after 5 years was 70% and 43% of all deaths were cardiac related. The paraplegia rate was 10%, the rate of patients developing chronic renal failure requiring hemodialysis was 3% and 21% of patients required surgical revision. In multivariate analyses the need for surgical revision (OR: 8.465; CI: 0.802-89.318; p=0.024) and postoperative elevated serum transaminase values (OR: 1.009; CI: 1.002-1.017; p=0.017) independently predicted 30-day mortality. Peripheral arterial disease (OR: 4.41; CI:1.672-11.611; p=0.003), intraoperative complications such as disseminated intravasal coagulation and asystole (OR: 4.28; CI: 1.128-16.267; p=0.033), postoperative elevated bilirubin values >2.5 mg/dl (OR: 1.06; CI: 1.009-1.112; p=0.019), and postoperative ventilation >7 days (OR: 7.79; CI: 2.499-24.246; p<0,0001) independently predicted long-term mortality. CONCLUSION: Postoperative elevated liver values represent negative prognostic factors and may indicate a more standardized use of active shunt systems for organ perfusion.
Authors: Marc A A M Schepens; Johannes C Kelder; Wim J Morshuis; Robin H Heijmen; Eric P van Dongen; Huub T M ter Beek Journal: Ann Thorac Surg Date: 2007-02 Impact factor: 4.330
Authors: Michael J Jacobs; Bas A de Mol; Ted Elenbaas; Werner H Mess; Cor J Kalkman; Geert W Schurink; Bas Mochtar Journal: J Vasc Surg Date: 2002-01 Impact factor: 4.268
Authors: H J Safi; C C Miller; M H Subramaniam; M P Campbell; D C Iliopoulos; J J O'Donnell; M J Reardon; G V Letsou; R Espada Journal: J Vasc Surg Date: 1998-10 Impact factor: 4.268
Authors: S L Drinkwater; D Böckler; H Eckstein; N J W Cheshire; D Kotelis; O Wolf; M S Hamady; P Geisbüsch; M Clark; J R Allenberg; J H Wolfe; R G Gibbs; M P Jenkins Journal: Eur J Vasc Endovasc Surg Date: 2009-08-08 Impact factor: 7.069
Authors: John E Rectenwald; Thomas S Huber; Tomas D Martin; C Keith Ozaki; Meenakshi Devidas; M Burress Welborn; James M Seeger Journal: J Vasc Surg Date: 2002-04 Impact factor: 4.268
Authors: Marc Schepens; Karl Dossche; Wim Morshuis; Robin Heijmen; Eric van Dongen; Huub Ter Beek; Hans Kelder; Eduard Boezeman Journal: Eur J Cardiothorac Surg Date: 2004-05 Impact factor: 4.191
Authors: David A Rigberg; Marcia L McGory; David S Zingmond; Melinda A Maggard; Michelle Agustin; Peter F Lawrence; Clifford Y Ko Journal: J Vasc Surg Date: 2006-02 Impact factor: 4.268